AAAAAA

   
Results: 1-11 |
Results: 11
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
Authors: Lazarus, HM Loberiza, FR Zhang, MJ Armitage, JO Ballen, KK Bashey, A Bolwell, BJ Burns, LJ Freytes, CO Galeg, RP Gibson, J Herzig, RH LeMaistre, CF Marks, D Mason, J Miller, AM Milone, GA Pavlovsky, S Reece, DE Rizzo, JD van Besien, K Vose, JM Horowitz, MM
Citation: Hm. Lazarus et al., Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR), BONE MAR TR, 27(4), 2001, pp. 387-396
Mobilization of peripheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxel
Authors: Fleming, DR Goldsmith, J Goldsmith, GH Stevens, DA Herzig, RH
Citation: Dr. Fleming et al., Mobilization of peripheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxel, J HEMATH ST, 9(6), 2000, pp. 855-860
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia
Authors: Davies, SM Ramsay, NKC Klein, JP Weisdorf, DJ Bolwell, B Cahn, JY Camitta, BM Gale, RP Giralt, S Heilmann, C Henslee-Downey, PJ Herzig, RH Hutchinson, R Keating, A Lazarus, HM Milone, GA Neudorf, S Perez, WS Powles, RL Prentice, HG Schiller, G Socie, G Vowels, M Wiley, J Yeager, A Horowitz, MM
Citation: Sm. Davies et al., Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia, J CL ONCOL, 18(2), 2000, pp. 340-347
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group
Authors: Wolff, SN Fay, J Stevens, D Herzig, RH Pohlman, B Bolwell, B Lynch, J Ericson, S Freytes, CO LeMaistre, F Collins, R Pineiro, L Greer, J Stein, R Goodman, SA Dummer, S
Citation: Sn. Wolff et al., Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group, BONE MAR TR, 25(8), 2000, pp. 853-859
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry
Authors: Giralt, S Szydio, R Goldman, JM Veum-Stone, J Biggs, JC Herzig, RH Klein, JP McGlave, PB Schiller, G Gale, RP Rowlings, PA Horowitz, MM
Citation: S. Giralt et al., Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry, BLOOD, 95(2), 2000, pp. 410-415
T-cell depletion of bone marrow transplants for leukemia from donors otherthan HLA-identical siblings: advantage of T-cell antibodies with narrow specificities
Authors: Champlin, RE Passweg, JR Zhang, MJ Rowlings, PA Pelz, CJ Atkinson, KA Barrett, AJ Cahn, JY Drobyski, WR Gale, RP Goldman, JM Gratwohl, A Gordon-Smith, EC Henslee-Downey, PJ Herzig, RH Klein, JP Marmont, AM O'Reilly, RJ Ringden, O Slavin, S Sobocinski, KA Speck, B Weiner, RS Horowitz, MM
Citation: Re. Champlin et al., T-cell depletion of bone marrow transplants for leukemia from donors otherthan HLA-identical siblings: advantage of T-cell antibodies with narrow specificities, BLOOD, 95(12), 2000, pp. 3996-4003
Ex vivo expansion of CD34(+) umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines
Authors: Qiu, LG Meagher, R Welhausen, S Heye, M Brown, R Herzig, RH
Citation: Lg. Qiu et al., Ex vivo expansion of CD34(+) umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines, J HEMATH ST, 8(6), 1999, pp. 609-618
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the north American marrow transplant group
Authors: Fleming, DR Wolff, SN Fay, JW Brown, RA Lynch, JP Bolwell, BJ Stevens, DA Goodman, SA Greer, JP Stein, RS Pineiro, LA Collins, RH Goldsmith, LJ Herzig, GP Herzig, RH
Citation: Dr. Fleming et al., Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the north American marrow transplant group, LEUK LYMPH, 35(1-2), 1999, pp. 91-98
Dose-intensive chemotherapy for breast cancer with brain metastases - A case series
Authors: Fleming, DR Goldsmith, GC Stevens, DA Herzig, RH
Citation: Dr. Fleming et al., Dose-intensive chemotherapy for breast cancer with brain metastases - A case series, AM J CL ONC, 22(4), 1999, pp. 371-374
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer
Authors: Rowlings, PA Williams, SF Antman, KH Fields, KK Fay, JW Reed, E Pelz, CJ Klein, JP Sobocinski, KA Kennedy, MJ Freytes, CO McCarthy, PL Herzig, RH Stadtmauer, EA Lazarus, HM Pecora, AL Bitran, JD Wolff, SN Gale, RP Armitage, JO Vaughan, WP Spitzer, G Horowitz, MM
Citation: Pa. Rowlings et al., Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer, J AM MED A, 282(14), 1999, pp. 1335-1343
The transfusion needs of an autologous bone marrow transplant patient withIgA deficiency
Authors: Meena-Leist, CE Fleming, DR Heye, M Herzig, RH
Citation: Ce. Meena-leist et al., The transfusion needs of an autologous bone marrow transplant patient withIgA deficiency, TRANSFUSION, 39(5), 1999, pp. 457-459
Risultati: 1-11 |